Beranda › Glioblastoma › Minnesota › Rochester
Uji klinis Glioblastoma di Rochester, MN
13 studi untuk Glioblastoma mencari peserta di lokasi sekitar Rochester (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Menerima pesertaFase 2
- Mayo Clinic in Rochester, Rochester
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Menerima pesertaFase 1/2
- Mayo Clinic in Rochester, Rochester
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Menerima pesertaFase 3
- Mayo Clinic - Rochester, Rochester
Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
Menerima pesertaFase awal 1
- Mayo Clinic in Rochester, Rochester
Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions
Menerima peserta
- Mayo Clinic in Rochester, Rochester
Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
Menerima peserta
- Mayo Clinic in Rochester, Rochester
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
Menerima peserta
- Mayo Clinic in Rochester, Rochester
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Menerima pesertaFase 2
- Mayo Clinic, Rochester
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Menerima pesertaFase 1/2
- Mayo Clinic in Rochester, Rochester
ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
Menerima pesertaFase 1
- Mayo Clinic in Rochester, Rochester
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
Menerima pesertaFase 1/2
- Mayo Clinic Hospital, Rochester
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Menerima pesertaFase 1/2
- Mayo Clinic Cancer Center, Rochester
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
Menerima pesertaFase 2
- Mayo Clinic, Rochester
Uji klinis Glioblastoma di kota lain
- New York City, NY30 studi
- Boston, MA28 studi
- Houston, TX26 studi
- Los Angeles, CA24 studi
- Durham, NC20 studi
- San Francisco, CA17 studi
- Chicago, IL15 studi
- Washington, DC15 studi
- Columbus, OH14 studi
- Miami, FL14 studi
- Jacksonville, FL13 studi
- Aurora, CO12 studi
Studi lain di Rochester
- Kanker Payudara42 studi
- Kanker Paru Non-Sel Kecil37 studi
- Kanker Metastatik31 studi
- Kanker (semua jenis)30 studi
- Kanker Ovarium29 studi
- Kanker Kolorektal29 studi
- Mieloma Multipel24 studi
- Gagal Jantung22 studi
- Kanker Prostat22 studi
- Kanker Pankreas22 studi
- Kanker Endometrium20 studi
- Kanker Paru20 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.